CAS 123931-40-8
:11,12-Eet
- 5,8-Decadienoic acid, 10-[(2S,3R)-3-(2Z)-2-octen-1-yl-2-oxiranyl]-, (5Z,8Z)-
- 11,12-Epoxy-(5Z,8Z,14Z)-eicosatrienoic acid ~100 mug/mL in ethanol, >=95%
(±)11(12)-EET
CAS :(±)11(12)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.[1][2][3[]A higher
Formule :C20H32O3Couleur et forme :SolidMasse moléculaire :320.4711,(12)-epoxy-5(Z),8(Z),14(Z)-eicosatrienoic acid
CAS :Formule :C20H32O3Degré de pureté :>95%Couleur et forme :In solution, EthanolMasse moléculaire :320.4714(15)-Epoxy-5Z,8Z,11Z-eicosatrienoic Acid-D11
CAS :Produit contrôléFormule :C20D11H21O3Couleur et forme :NeatMasse moléculaire :331.53411,12-EET
CAS :11,12-EET is an analog of the human protein that has been found to have potential medicinal benefits in the treatment of cancer. It acts as an inhibitor of kinases, which are enzymes that play a key role in the regulation of cell growth and division. 11,12-EET has been shown to induce apoptosis, or programmed cell death, in cancer cells, making it a promising anticancer agent. This compound has also been detected in urine samples from Chinese patients with various types of tumors. Ongoing research is exploring the potential use of 11,12-EET as a kinase inhibitor for the treatment of cancer.
Formule :C20H32O3Degré de pureté :Min. 95%Masse moléculaire :320.5 g/mol




